BABA
Alibaba Group Holding Limited
BABA has a slight edge over CURV overall, supported by lower modeled downside.
CURV
Torrid Holdings Inc.
CURV offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
CURV Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Weak |
CURV's revenue, profitability, cash flow and balance sheet are all currently under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
CURV PE Valuation
CURV has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 40x next year's earnings.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over CURV on the outlook, with more favorable revenue expectations.
CURV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CURV to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over CURV on earnings quality, reporting a profit while its opponent remains loss making.
CURV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.06 | — |
| Q3 2026 | -$0.10 | -433% |
| Q2 2026 | -$0.13 | -244% |
| Q1 2026 | -$0.07 | -147% |
| Q4 2025 | -$0.02 | -113% |
| Q3 2025 | $0.03 | -79% |
| Q2 2025 | $0.09 | -25% |
| Q1 2025 | $0.15 | +36% |
| Q4 2024 | $0.16 | +60% |
CURV has swung to a loss: it lost $0.10 per share over the past year, after a profit the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over CURV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over CURV on profitability, with a higher operating margin.
CURV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $231.7M | -12% |
| Q2 2026 | $245.8M | -7.6% |
| Q1 2026 | $236.2M | -14% |
| Q4 2025 | $235.2M | -11% |
| Q3 2025 | $262.8M | -7.7% |
| Q2 2025 | $266M | -4.9% |
| Q1 2025 | $275.6M | -6.1% |
| Q4 2024 | $263.8M | -4.2% |
CURV's revenue has slid since its 2022 peak: $232M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | +2.4 points |
| Q2 2026 | 3.5% | -2.6 points |
| Q1 2026 | -2.1% | -3.4 points |
| Q4 2025 | 0.1% | -2.6 points |
| Q3 2025 | 3.9% | -3.3 points |
| Q2 2025 | 6% | -3.3 points |
| Q1 2025 | 1.3% | -0.1 points |
| Q4 2024 | 2.7% | +0.2 points |
CURV's operating margin was 6.3% last quarter, up 2.4 points from the same quarter a year ago.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
CURV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3M | -121% |
| Q2 2026 | $5.7M | +$26.3M |
| Q1 2026 | -$9.3M | -191% |
| Q4 2025 | -$6.6M | -$1.1M |
| Q3 2025 | $14.6M | -61% |
| Q2 2025 | -$20.6M | -200% |
| Q1 2025 | $10.2M | +$12M |
| Q4 2024 | -$5.5M | -$1.9M |
CURV has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
CURV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +667K shares |
| 1 year | -2.5% | -2.5M shares |
| 3 years | -3.8% | -4M shares |
| 5 years | -8.9% | -9.8M shares |
| Available history | -8.9% | -9.8M shares |
CURV has the edge over BABA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $186,000 |
| Q1 2026 | — |
| Q4 2025 | $85,000 |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CURV spent $271,000 buying back its own shares over the past year.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA has the edge over CURV on leverage, with a lower net debt burden relative to earnings.
CURV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | 5.2x | High |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 3.9x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.1x | Elevated |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | 2.6x | Moderate |
CURV's net debt is about 5.2 years of its operating earnings (EBITDA), up from 3.5 years a year ago.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
CURV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 35.0 | Neutral |
CURV's weekly RSI is 51 (neutral) and its Stochastic is 35 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
CURV PE vs Consumer Cyclical Sector
| Metric | CURV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CURV has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
CURV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.33 | 4.3% below |
| 20 week MA | $2.30 | 3% below |
| 50 week MA | $1.78 | 25% above |
| 100 week MA | $2.88 | 23% below |
| 200 week MA | $3.56 | 37% below |
CURV has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
CURV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $26.6 | $10.1 | -62% |
| 2022 | $10.1 | $3.02 | -70% |
| 2023 | $3.02 | $5.77 | +91% |
| 2024 | $5.77 | $5.28 | -8.5% |
| 2025 | $5.28 | $1.04 | -80% |
| 2026 YTD | $1.04 | $2.23 | +114% |
CURV has the edge over BABA on returns for 2026, with the stronger performance.